Amanta Healthcare
AMANTA NSE
Amanta Healthcare
HealthcareNSE: AMANTA BSE: 544502 Pharmaceuticals
Key Fundamentals
MicrocapPharmaceuticalsHealthcareMarket Cap
₹784 Cr
Volatility
Moderate
P/E Ratio
52.45
EBITDA
₹63.20 Cr
Return on Equity
6.75%
Debt to Equity
1.11
Book Value
₹56.71
52W High
₹209.95
52W Low
₹92
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
1- Company has delivered good profit growth of 22.4% CAGR over last 5 years
Weaknesses
4- Stock is trading at 3.49 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of 10.9% over past five years.
- Company has a low return on equity of 10.0% over last 3 years.
Growth Rate
Revenue Growth
5.4% higher than
3Y
Net Income Growth
41.9% lower than
3Y
Cash Flow Change
3.93% higher than
3Y
ROE
-38.02% lower than
3Y
ROCE
-37.21% lower than
3Y
EBITDA Margin (Avg.)
-1.76% lower than
3Y
Quarterly Results
| Particulars | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 68.1 | 66.73 | 67.81 | 72.06 | 65.31 | 70.89 | 74.49 | 76.99 | 68.8 |
| Expenses | 54.7 | 52.85 | 52.75 | 53.1 | 50.41 | 56.24 | 59.13 | 62.03 | 54.26 |
| Operating Profit | 13.4 | 13.88 | 15.06 | 18.96 | 14.9 | 14.65 | 15.36 | 14.96 | 14.54 |
| OPM % | 19.68% | 20.8% | 22.21% | 26.31% | 22.81% | 20.67% | 20.62% | 19.43% | 21.13% |
| Other Income | 0.15 | 0.21 | 0.87 | 0.16 | 0.96 | -2.56 | 0.68 | 1.66 | 0.64 |
| Interest | 9.45 | 6.32 | 5.9 | 6.28 | 6.29 | 5.15 | 5.06 | 4.25 | 6 |
| Depreciation | 4.6 | 4.6 | 4.51 | 4.69 | 4.64 | 4.66 | 4.67 | 4.75 | 4.69 |
| PBT | -0.5 | 3.17 | 5.52 | 8.15 | 4.93 | 2.28 | 6.31 | 7.62 | 4.49 |
| Tax % | -28% | 28.71% | 22.64% | 26.87% | 28.8% | 46.93% | 26.47% | 27.43% | 26.28% |
| Net Profit | -0.36 | 2.26 | 4.28 | 5.96 | 3.51 | 1.21 | 4.63 | 5.53 | 3.31 |
| EPS in Rs | -0.13 | 0.78 | 1.48 | 2.07 | 1.22 | 0.31 | 1.19 | 1.42 | 0.85 |
Profit & Loss
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 184 | 171 | 225 | 259 | 280 | 275 | 288 | 291 |
| Expenses | 147 | 133 | 173 | 206 | 223 | 215 | 228 | 232 |
| Operating Profit | 37 | 38 | 52 | 53 | 58 | 60 | 60 | 60 |
| OPM % | 20% | 22% | 23% | 20% | 21% | 22% | 21% | 20% |
| Other Income | 2 | 1 | 76 | 4 | 1 | 1 | 1 | 0 |
| Interest | 38 | 40 | 49 | 35 | 34 | 28 | 21 | 20 |
| Depreciation | 16 | 17 | 17 | 18 | 20 | 18 | 19 | 19 |
| PBT | -15 | -18 | 62 | 3 | 5 | 15 | 21 | 21 |
| Tax % | 25% | 23% | 11% | 179% | 32% | 29% | 30% | — |
| Net Profit | -19 | -22 | 55 | -2 | 4 | 10 | 15 | 15 |
| EPS in Rs | -7.03 | -8.14 | 20.54 | -0.79 | 1.35 | 3.64 | 3.83 | 3.77 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 27 | 27 | 27 | 27 | 27 | 29 | 39 |
| Reserves | 2 | -20 | 36 | 36 | 39 | 68 | 181 |
| Borrowings | 231 | 235 | 226 | 216 | 211 | 204 | 244 |
| Other Liabilities | 127 | 150 | 104 | 96 | 75 | 81 | 93 |
| Total Liabilities | 388 | 392 | 392 | 374 | 352 | 382 | 558 |
| Fixed Assets | 244 | 242 | 240 | 232 | 228 | 217 | 207 |
| CWIP | 0 | 0 | 0 | 9 | 0 | 7 | 82 |
| Investments | 0 | 2 | 3 | 0 | 4 | 8 | 7 |
| Other Assets | 144 | 149 | 149 | 133 | 120 | 150 | 262 |
| Total Assets | 388 | 392 | 392 | 374 | 352 | 382 | 558 |
Cash Flow
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Operating | 38 | 31 | 62 | 43 | 58 | 47 | 48 |
| Investing | -9 | -13 | -6 | -7 | -10 | -24 | -94 |
| Financing | -37 | -18 | -50 | -42 | -46 | -23 | 126 |
| Net Cash Flow | -8 | 0 | 6 | -6 | 1 | -1 | 81 |
| Free Cash Flow | 27 | 19 | 52 | 36 | 46 | 26 | -32 |
| CFO/OP | 102 | 66 | 119 | 93 | 111 | 84 | 93 |
Ratios
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 104 | 110 | 73 | 75 | 63 | 67 | 55 |
| Inventory Days | 225 | 422 | 338 | 247 | 309 | 464 | 530 |
| Days Payable | 99 | 186 | 185 | 130 | 129 | 194 | 230 |
| Cash Conversion Cycle | 229 | 345 | 226 | 193 | 243 | 336 | 354 |
| Working Capital Days | 51 | -5 | 28 | 42 | 16 | 26 | 6 |
| ROCE % | — | 9% | 14% | 13% | 14% | 15% | 12% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Amanta Healthcare insights
58 extracted metrics + investor summaries across FY16–FY27.
Documents
1
Board Meeting Intimation for To Consider And Approve The Financial Results For The Period Ended March 31, 2026
10h - Board meets May 19, 2026 to approve audited FY26 results; trading window reopens May 22, 2026. 10h - Board meets May 19, 2026 to approve audited FY26 results; trading window reopens May 22, 2026.
2
Clarification Letter On Earlier Disclosure Submitted On April 18Th, 2026, Pursuant To SEBI (PIT) Regulations, 2015
22 Apr - Promoter Bhavesh Patel’s 15,500 shares credited on April 17, 2026; holding rose to 16.29%. 22 Apr - Promoter Bhavesh Patel’s 15,500 shares credited on April 17, 2026; holding rose to 16.29%.
3
Clarification Letter On Earlier Disclosure Submitted On April 18Th, 2026, Pursuant To SEBI (PIT) Regulations, 2015
10h - Promoter Bhavesh Patel’s 15,500 shares credited on April 17, 2026; holding rose to 16.29%. 10h - Promoter Bhavesh Patel’s 15,500 shares credited on April 17, 2026; holding rose to 16.29%.
4
Clarification On Earlier Disclosure Submitted On April 1St, 2026
18 Apr - Promoter Bhavesh Patel actually received 13,300 shares, not 28,800; earlier disclosure revised. 18 Apr - Promoter Bhavesh Patel actually received 13,300 shares, not 28,800; earlier disclosure revised.
5
Announcement under Regulation 30 (LODR)-Change in Management
16 Apr - AVP HR & Admin Shri Vimal Shrimali resigned effective April 16, 2026. 16 Apr - AVP HR & Admin Shri Vimal Shrimali resigned effective April 16, 2026.
Frequently Asked Questions about Amanta Healthcare
What does Amanta Healthcare Ltd do?
Incorporated in December 1994, Amanta Healthcare Limited is a pharmaceutical company that specializes in the development, manufacturing, and marketing of a diverse array of sterile liquid products.[1]
Where is Amanta Healthcare Ltd (AMANTA) listed?
Amanta Healthcare Ltd trades as AMANTA on the NSE and under code 544502 on the BSE.
Which sector does Amanta Healthcare Ltd belong to?
Amanta Healthcare Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Amanta Healthcare Ltd?
Amanta Healthcare Ltd has a market capitalisation of ₹783.5 Cr, which places it in the Small Cap band.
What is the PE ratio of Amanta Healthcare Ltd?
Amanta Healthcare Ltd trades at a PE ratio of 52.45, against a book value of ₹56.71 per share.
What is the 52-week high and low of Amanta Healthcare Ltd?
Over the last 52 weeks Amanta Healthcare Ltd has traded between ₹92 and ₹209.95.
What is the Return on Equity (ROE) of Amanta Healthcare Ltd?
Amanta Healthcare Ltd reported a return on equity of 6.75%. Its debt-to-equity ratio is 1.11.
Company Information
Incorporated in December 1994, Amanta Healthcare Limited is a pharmaceutical company that specializes in the development, manufacturing, and marketing of a diverse array of sterile liquid products.[1]
Website amanta.co.in
CEO Mr. Bhavesh Girishbhai Patel
Listed 2025-09-09
Face Value ₹ 10
Issued Size 3,88,29,351
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/AMANTA.md for Amanta Healthcare Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.